CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Sale | −100 | $121.56 | $12K | 0 |
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Exercise or conversion · Share Option (Right to Buy) | −156,871 | 1,080,000 | ||
| 2018-11-09 | Peterson Amy C. CMO, Immuno-oncology | Exercise or conversion | +13,222 | $29.10 | $385K | 13,222 |
| 2018-11-09 | Peterson Amy C. CMO, Immuno-oncology | Sale | −4,031 | $118.64 | $478K | 9,191 |
| 2018-11-09 | Peterson Amy C. CMO, Immuno-oncology | Sale | −1,725 | $119.27 | $206K | 7,466 |
| 2018-11-09 | Peterson Amy C. CMO, Immuno-oncology | Sale | −2,100 | $120.63 | $253K | 5,366 |
| 2018-11-09 | Peterson Amy C. CMO, Immuno-oncology | Sale | −2,898 | $121.71 | $353K | 2,468 |
| 2018-11-09 | Peterson Amy C. CMO, Immuno-oncology | Sale | −2,046 | $122.55 | $251K | 422 |
| 2018-11-09 | Peterson Amy C. CMO, Immuno-oncology | Sale | −322 | $123.75 | $40K | 100 |
| 2018-11-09 | Peterson Amy C. CMO, Immuno-oncology | Sale | −100 | $125.97 | $13K | 0 |
| 2018-11-09 | Peterson Amy C. CMO, Immuno-oncology | Exercise or conversion · Share Option (Right to Buy) | −171,886 | 1,236,871 | ||
| 2018-11-08 | Peterson Amy C. CMO, Immuno-oncology | Exercise or conversion | +14,711 | $29.10 | $428K | 14,711 |
| 2018-11-08 | Peterson Amy C. CMO, Immuno-oncology | Sale | −466 | $122.86 | $57K | 14,245 |
| 2018-11-08 | Peterson Amy C. CMO, Immuno-oncology | Sale | −2,423 | $124.48 | $302K | 11,822 |
| 2018-11-08 | Peterson Amy C. CMO, Immuno-oncology | Sale | −3,949 | $126.08 | $498K | 7,873 |
| 2018-11-08 | Peterson Amy C. CMO, Immuno-oncology | Sale | −7,673 | $126.72 | $972K | 200 |
| 2018-11-08 | Peterson Amy C. CMO, Immuno-oncology | Sale | −200 | $127.61 | $26K | 0 |
| 2018-11-08 | Peterson Amy C. CMO, Immuno-oncology | Exercise or conversion · Share Option (Right to Buy) | −191,243 | 1,408,757 | ||
| 2018-09-04 | Huang Jane CMO, Hematology | Sale | −2,911 | $174.60 | $508K | 0 |
| 2018-08-30 | Glazer Donald W. Director | Sale | −1,000 | $179.00 | $179K | 13,384 |
Page 109 of 123 · 2,455 trades